HC
PFE icon

Hurley Capital’s Pfizer PFE Stock Holding History

Hurley Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40K Sell
1,663
-75
-4% -$1.96K 0.02% 210
2026
Q1 		$48.8K Buy
1,738
+168
+11% +$4.47K 0.03% 176
2025
Q4 		$39.1K Buy
1,570
+4
+0.3% +$101 0.02% 190
2025
Q3 		$39.9K Sell
1,566
-657
-30% -$16.2K 0.02% 218
2025
Q2 		$53.9K Buy
2,223
+801
+56% +$18.7K 0.04% 151
2025
Q1 		$36K Sell
1,422
-1,793
-56% -$46.9K 0.03% 202
2024
Q4 		$86.3K Buy
+3,215
New +$87.2K 0.07% 102

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Hurley Capital's PFE Position: Q2 2026 in Review

Hurley Capital reduced its Pfizer (PFE) stake by 4.3% in Q2 2026, selling an estimated $1.96K and leaving 1,663 shares worth $40K. The position accounts for 0.02% of the portfolio, ranked #210.

Hurley Capital first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $86.3K in Q4 2024. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Hurley Capital held 1,663 shares of Pfizer worth $40K as of Q2 2026.
  • Hurley Capital sold 75 Pfizer shares in Q2 2026, an estimated $1.96K.
  • Pfizer made up 0.02% of Hurley Capital's portfolio in Q2 2026, its #210 holding.
  • Hurley Capital first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Hurley Capital's Pfizer position peaked at $86.3K in Q4 2024.
  • 2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Hurley Capital's 13F filing for Q2 2026, filed 10 Aug 2026.